Literature DB >> 2045759

The effect of dietary vitamin K on warfarin-induced anticoagulation.

F M Pedersen1, O Hamberg, K Hess, L Ovesen.   

Abstract

We examined the effect of vitamin-K-rich vegetables, vitamin-K-poor vegetables and phytomenadione on the stability of warfarin-induced anticoagulation. Patients on stable anticoagulant treatment were randomized to either 1 (n = 5), 2 (n = 7) or 7 (n = 13) d with high intake of vitamin-K-rich vegetables (median daily vitamin K intake 1100 micrograms) or high intake of vitamin-K-poor vegetables (daily vitamin K intake 135 micrograms) for 6 d (n = 7), or habitual diet supplemented with 1000 micrograms of phytomenadione daily (n = 5). Nine patients (69%; 95% CI, 39-91%) who consumed vitamin-K-rich vegetables for 7 d reached activities above the therapeutic level. Two (40%; 95% CI, 5-85%) and three patients (43%; 95% CI, 10-86%) who consumed vitamin-K-rich vegetables for 1 and 2 d, respectively, exceeded the upper therapeutic limit. No changes were observed in the vitamin-K-poor group. All patients who received phytomenadione exceeded the upper therapeutic limit. Dietary vitamin K should be regarded as an important environmental factor contributing to unwanted disturbances in warfarin-induced anticoagulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045759     DOI: 10.1111/j.1365-2796.1991.tb00388.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  Use of oral anticoagulants in older patients.

Authors:  J L Sebastian; D D Tresch
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.

Authors:  Y-E Kim; H I Woo; Y K On; J S Kim; S-Y Lee
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

3.  Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis.

Authors:  Edith A Nutescu; Cathy M Helgason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

Review 4.  Anticoagulant therapy in special circumstances.

Authors:  T G DeLoughery
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

5.  Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: a prospective cohort study.

Authors:  Ron C Li; Brian S Finkelman; Jinbo Chen; Sarah L Booth; Luanne Bershaw; Colleen Brensinger; Stephen E Kimmel
Journal:  Thromb Haemost       Date:  2013-03-21       Impact factor: 5.249

6.  Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation.

Authors:  Inna Y Gong; Ute I Schwarz; Natalie Crown; George K Dresser; Alejandro Lazo-Langner; GuangYong Zou; Dan M Roden; C Michael Stein; Marc Rodger; Philip S Wells; Richard B Kim; Rommel G Tirona
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

7.  Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review.

Authors:  Francesco Violi; Gregory Yh Lip; Pasquale Pignatelli; Daniele Pastori
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.